Related Experiment Video
Updated: Jul 4, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Clinical Pathways and Digital Twins in MIMIC-IV: A Proof-of-Concept Study.
William Røise1, Ankica Babic1,2
1Department of Information Science and Media Studies, University of Bergen, Norway.
Studies in Health Technology and Informatics
|July 3, 2026
Summary
The Medical Information Mart for Intensive Care IV (MIMIC-IV) database supports clinical pathway reconstruction and digital twin creation. Machine learning can automatically update these pathways with new patient data.
Area of Science:
- Clinical Informatics
- Health Data Science
- Machine Learning in Healthcare
Background:
- Electronic health records (EHRs) contain rich temporal data.
- Clinical pathway analysis is crucial for understanding patient journeys.
- Digital twins offer a novel approach to personalized medicine.
Purpose of the Study:
- To assess the utility of the MIMIC-IV database for constructing clinical pathways.
- To explore the feasibility of creating proof-of-concept digital twins from MIMIC-IV data.
- To investigate the potential of machine learning for automated pathway updates.
Main Methods:
- Reconstruction of patient-level event logs from MIMIC-IV using admissions, diagnoses, and procedures.
- Utilization of directed graphs for visualizing patient trajectories.
- Development of a baseline machine learning pipeline for regenerating predictive features.
Main Results:
- MIMIC-IV provides sufficient temporal detail for event ordering and pathway-outcome linkage.
- The database supports the reconstruction of heterogeneous clinical pathways.
- A machine learning pipeline demonstrated the capability to update pathways with new data.
Conclusions:
- MIMIC-IV is a suitable resource for clinical pathway and digital twin construction.
- Automated pathway updates using machine learning are feasible.
- Findings are based on a US-centric database and proof-of-concept design, requiring cautious interpretation for generalizability.
Related Concept Videos
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...